Xaira Therapeutics
CA - South SFBiotechnology
Focus: Xaira Therapeutics is an AI-driven drug discovery company founded in 2024, leveraging artificial intelligence to accelerate therapeutic development across ophthalmology, neurology, and gene therapy. The company is in early-stage build-out with 28 active job openings and is headquartered in South San Francisco.
Profile data last refreshed 10h ago · AI intelligence enriched 3w ago
Open Jobs
32+6 this month
Growing — net +6 jobs in 30d
7 jobs added vs 1 removed. Steady team buildout.
Should You Work at Xaira Therapeutics?
AI assessmentXaira represents a high-risk, high-upside early-stage bet for technologists and AI-forward scientists willing to trade stability for equity and platform-building impact.
Why Work Here
- Ground-floor opportunity at a 2024-founded company backed by recent leadership expansions and active dealmaking with external partners (July 2026 news)
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Xaira Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.